GENEVA, July 27 -- NUALTIS CORP. filed a patent application (CA2026/050089) for “TRANSMUCOSAL ORAL DOSAGE FORM AND METHOD OF USING THE SAME”. With publication no. WO/2026/152239, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/22
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....